EphMRA Online Panel Discussion – The future transformation of Market Research – where will it be in 10 years from now?

We are all well aware that COVID-19 has been a major impetus for change in the world and not least in the healthcare market research/BI industry. The future of market research in our industry is evolving and changing due to the pandemic in particular, so it’s a great time to take stock and see where the industry is heading over the next few years. EphMRA is running a panel discussion on 11 May which will comprise of panellists from industry.

We currently have on board:

Yvonne Engler, VP, Head of Customer & Business Insights CV/WHC/Pulm core and pipeline brands at Bayer Pharma AG

Karsten Trautmann, EphMRA President & Head of GSI Center of Excellence, Merck Healthcare KGaA

Artur Pieniadz, EU Cluster Market Research, Business Insights and Analytics, Bristol Myers Squibb

Andrew Bajorek, Director, Business Intelligence, Neuroscience EUR/INT, Jazz Pharmaceuticals

Click Below For Zoom Meeting
https://zoom.us/meeting/register/tJwkcOyhpjgtH9KTV5ViVu8TisxNj3I-IXSn